General form of registration statement for all companies including face-amount certificate companies

SHARE CAPITAL - Narrative (Details)

v3.22.0.1
SHARE CAPITAL - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2021
USD ($)
shares
Dec. 01, 2020
shares
Sep. 30, 2021
$ / shares
shares
Sep. 30, 2020
shares
Jun. 30, 2020
$ / shares
shares
Sep. 30, 2021
$ / shares
shares
Sep. 30, 2020
USD ($)
Aug. 31, 2021
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Dec. 31, 2019
$ / shares
shares
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                    
Common stock, shares authorized     180,000,000     180,000,000   900,000,000 180,000,000  
Common stock, par value (in dollars per share) | $ / shares     $ 0.001     $ 0.001   $ 0.001 $ 0.001 $ 0.001
Common stock, shares issued     11,839,304     11,839,304     11,275,788 34,795,313
Common stock, shares outstanding     11,839,304     11,839,304     11,275,788 34,795,313
Reverse stock split ratio     0.2 0.2            
Fractional shares issued       0            
Shares issued   16,357,703     156,032          
Share price | $ / shares         $ 4.00          
Outstanding principal | $             $ 60,000,000      
Shares issued on conversion of debt           13,384        
Sentry Neuromonitoring, LLC                    
Business Acquisition, Equity Interests Issued or Issuable [Line Items]                    
Value of common stock issuable | $ $ 1,625,000                  
Common stock issuable 237,226                  
Held in escrow, Value | $ $ 650,000                  
Held in escrow, Shares 94,891                  
Common stock lock up period 12 months